Millennium Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$102M Buy
1,622,204
+32,327
+2% +$2.25M 0.04% 436
2025
Q4
$106M Sell
1,589,877
-1,841,388
-54% -$119M 0.04% 414
2025
Q3
$231M Buy
3,431,265
+3,179,954
+1,265% +$252M 0.1% 163
2025
Q2
$21.9M Sell
251,311
-95,227
-27% -$7.46M 0.01% 1492
2025
Q1
$23.7M Sell
346,538
-2,729,426
-89% -$223M 0.01% 1358
2024
Q4
$239M Buy
3,075,964
+2,734,321
+800% +$202M 0.12% 130
2024
Q3
$22.9M Buy
341,643
+277,152
+430% +$22.8M 0.01% 1427
2024
Q2
$7.31M Sell
64,491
-590,105
-90% -$74.6M ﹤0.01% 2353
2024
Q1
$90.8M Sell
654,596
-372,563
-36% -$46.8M 0.04% 500
2023
Q4
$127M Sell
1,027,159
-1,754,429
-63% -$179M 0.06% 333
2023
Q3
$260M Buy
2,781,588
+878,123
+46% +$99M 0.13% 100
2023
Q2
$245M Sell
1,903,465
-771,329
-29% -$93.3M 0.12% 105
2023
Q1
$311M Sell
2,674,794
-1,215,855
-31% -$136M 0.18% 61
2022
Q4
$441M Buy
3,890,649
+2,658,077
+216% +$292M 0.24% 29
2022
Q3
$99.3M Buy
1,232,572
+263,739
+27% +$22.3M 0.06% 331
2022
Q2
$72.2M Buy
968,833
+63,065
+7% +$5.76M 0.04% 443
2022
Q1
$116M Sell
905,768
-210,424
-19% -$23M 0.06% 283
2021
Q4
$150M Buy
1,116,192
+1,054,948
+1,723% +$152M 0.08% 216
2021
Q3
$8.37M Buy
+61,244
New +$7.72M 0.01% 2297
2021
Q2
Sell
-109,320
Closed -$10.5M 6632
2021
Q1
$9.82M Buy
109,320
+48,204
+79% +$4.52M 0.01% 1793
2020
Q4
$5.65M Sell
61,116
-385,176
-86% -$34.4M ﹤0.01% 2322
2020
Q3
$46K Sell
446,292
-344,312
-44% -$36M 0.06% 359
2020
Q2
$80.1M Buy
790,604
+398,036
+101% +$35.6M 0.11% 152
2020
Q1
$26.4M Sell
392,568
-985,540
-72% -$61.3M 0.06% 335
2019
Q4
$75.4M Buy
1,378,108
+1,156,792
+523% +$54.9M 0.09% 207
2019
Q3
$8.26M Sell
221,316
-1,639,752
-88% -$63.7M 0.01% 1416
2019
Q2
$69.7M Sell
1,861,068
-799,436
-30% -$25.1M 0.1% 208
2019
Q1
$79.2M Sell
2,660,504
-59,032
-2% -$2.07M 0.12% 200
2018
Q4
$81.5M Sell
2,719,536
-2,576,544
-49% -$81.7M 0.13% 189
2018
Q3
$189M Sell
5,296,080
-1,211,588
-19% -$37.6M 0.23% 61
2018
Q2
$155M Buy
6,507,668
+2,789,752
+75% +$59.1M 0.2% 86
2018
Q1
$68.9M Buy
3,717,916
+2,093,752
+129% +$31M 0.09% 299
2017
Q4
$23.3M Buy
+1,624,164
New +$21.1M 0.03% 804
2017
Q3
Sell
-99,072
Closed -$1.75M 3574
2017
Q2
$1.81M Sell
99,072
-260,064
-72% -$4.8M ﹤0.01% 2126
2017
Q1
$7.61M Buy
359,136
+330,724
+1,164% +$6.46M 0.01% 1191
2016
Q4
$424K Sell
28,412
-169,604
-86% -$3M ﹤0.01% 2755
2016
Q3
$4.34M Sell
198,016
-1,174,344
-86% -$26.1M 0.01% 1423
2016
Q2
$27.2M Buy
1,372,360
+177,964
+15% +$3.03M 0.06% 392
2016
Q1
$20.3M Sell
1,194,396
-465,568
-28% -$7.78M 0.05% 476
2015
Q4
$34M Buy
1,659,964
+1,131,056
+214% +$23.5M 0.07% 376
2015
Q3
$11.4M Sell
528,908
-1,465,580
-73% -$32.7M 0.02% 862
2015
Q2
$39.9M Sell
1,994,488
-1,476,176
-43% -$25.9M 0.08% 333
2015
Q1
$54.1M Buy
3,470,664
+2,825,816
+438% +$42.7M 0.1% 243
2014
Q4
$8.88M Buy
644,848
+510,696
+381% +$6.25M 0.02% 1066
2014
Q3
$1.34M Sell
134,152
-1,143,676
-90% -$11.7M ﹤0.01% 2114
2014
Q2
$12.7M Sell
1,277,828
-283,320
-18% -$2.51M 0.04% 704
2014
Q1
$16.1M Buy
1,561,148
+726,356
+87% +$7.51M 0.05% 556
2013
Q4
$7.39M Sell
834,792
-403,208
-33% -$3.19M 0.02% 905
2013
Q3
$8.73M Sell
1,238,000
-1,601,776
-56% -$10.1M 0.03% 762
2013
Q2
$15.9M Buy
+2,839,776
New +$13.6M 0.05% 402

Other funds holding DXCM

Millennium Management's DXCM Position: Q1 2026 in Review

Millennium Management increased its DexCom (DXCM) stake by 2% in Q1 2026, buying an estimated $2.25M and bringing the position to 1,622,204 shares worth $102M. The position accounts for 0.04% of the portfolio, ranked #436.

Millennium Management first reported a position in DXCM in Q2 2013 and has held it in 50 quarters since. The position peaked at $441M in Q4 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Millennium Management held 1,622,204 shares of DexCom worth $102M as of Q1 2026.
  • Millennium Management bought 32,327 DexCom shares in Q1 2026, an estimated $2.25M.
  • DexCom made up 0.04% of Millennium Management's portfolio in Q1 2026, its #436 holding.
  • Millennium Management first reported a position in DexCom in Q2 2013 and has held it in 50 quarters since.
  • Millennium Management's DexCom position peaked at $441M in Q4 2022.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.